On September 30 the U.S. Food and Drug Administration (FDA) approved, Relyvrio, a drug to slow the progression of ALS, also known as Lou Gehrig’s disease. The approval was controversial. The FDA usually requires at least two clinical trials but will on occasion accept one trial if the trial was robust and the data provides persuasive evidence…
Category: News and Events
Monday Links
- CBO: competition and price transparency are the best ways to lower private sector health care costs.
- Nurse fired for refusing to admit she’s a racist. (WSJ)
- Against hormone therapy for children.
- When the dangers of one type of drug addiction become widely known, teenagers switch to another addictive drug. (NYT)
- Why did McKinsey get into the addiction business? (NYT)
The Deck Is Stacked Against Boys
David Brooks in the New York Times:
American girls are 14 percentage points more likely to be “school ready” than boys at age 5, controlling for parental characteristics. By high school, two-thirds of the students in the top 10 percent of the class, ranked by G.P.A., are girls, while roughly two-thirds of the students at the lowest decile are boys….
The White House’s Vote-Buying Hunger Games
President Joe Biden announced his Administration’s plan to end hunger by 2030.
President Joe Biden said his administration will commit more than $8 billion in private and public sector funding as part of its plans to end hunger and reduce diet-related disease by 2030.
“I really know we can do this, end hunger in this country, by the year 2030 and lower the toll that diet-related diseases take on far too many Americans,” Biden said at a conference on hunger, nutrition and health in Washington on Wednesday. “This goal is within our reach. Just look at how far we’ve come on child poverty.”